Pluronic block copolymers enhance the anti-myeloma activity of proteasome inhibitors

Proteasome inhibitors (PIs) have markedly improved response rates as well as the survival of multiple myeloma (MM) patients over the past decade and have become an important foundation in the treatment of MM patients. Unfortunately, the majority of patients either relapses or becomes refractory to p...

Full description

Saved in:
Bibliographic Details
Published in:J Control Release
Main Authors: Hu, Hangting, Petrosyan, Armen, Osna, Natalia A., Liu, Tong, Olou, Appolinaire A., Alakhova, Daria Y., Singh, Pankaj K., Kabanov, Alexander V., Faber, Edward A., Bronich, Tatiana K.
Format: Artigo
Language:Inglês
Published: 2019
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6822276/
https://ncbi.nlm.nih.gov/pubmed/31121280
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jconrel.2019.05.026
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items